Skip to main content
    5/5 (600+ Google Reviews)Certified Medicare Insurance Planner®
    Medicare 2026 Drug Price Changes in Florida: What the New Part D Rules Mean for Your Prescriptions
    Back to Blog
    July 22, 2026

    Medicare 2026 Drug Price Changes in Florida: What the New Part D Rules Mean for Your Prescriptions

    Confused about how Medicare 2026 drug price changes Florida residents will see could impact what you pay at the pharmacy? We break down the first Medicare‑negotiated drug prices effective January 1, 2026 and the redesigned Part D out‑of‑pocket rules so you can make confident choices before Annual Enrollment. You’ll learn what changed, who’s affected, and how to compare Florida plan formularies the right way.

    What are the 2026 Medicare drug price changes in Florida—and why do they matter?

    For the first time, Medicare has negotiated “Maximum Fair Prices” (MFPs) for a set of high‑spend Part D drugs, and those negotiated prices take effect on January 1, 2026. Plans that serve Florida beneficiaries must reflect these prices and include the selected drugs on their formularies, which can lower overall spending and change which plans are the best value for your specific medications. This is a nationwide policy that directly affects Florida enrollees.

    CMS reports that if the negotiated prices had been in place earlier, total Medicare Part D spending on these drugs would have dropped substantially. For 2026, that translates into potential savings for many Floridians taking targeted therapies for heart disease, diabetes, autoimmune conditions, and certain cancers. Lower negotiated prices work alongside the new Part D benefit design to curb out‑of‑pocket shocks.

    Which prescriptions have negotiated Medicare prices on January 1, 2026?

    CMS finalized negotiated prices for 10 Part D drugs used by millions of beneficiaries. Drugs with negotiated prices include:

    • Eliquis (apixaban)
    • Xarelto (rivaroxaban)
    • Jardiance (empagliflozin)
    • Farxiga (dapagliflozin)
    • Januvia (sitagliptin)
    • Entresto (sacubitril/valsartan)
    • Enbrel (etanercept)
    • Stelara (ustekinumab)
    • Imbruvica (ibrutinib)
    • Insulin aspart products (Fiasp and NovoLog family)

    To illustrate the scale: the negotiated monthly price for Eliquis is $231 (vs. $521 list), Xarelto is $197 (vs. $517), and Enbrel is $2,355 (vs. $7,106). Florida members won’t all pay these exact dollar amounts at the counter—your coinsurance or copay still depends on plan tiering and pharmacy choice—but these benchmarks drive what plans can charge. Across the 10 drugs, reductions versus list price range roughly 38%–79%.

    a Jacksonville-area pharmacist speaking with a senior patient at the counter while reviewing a prescription bottle and printed plan information
    a Jacksonville-area pharmacist speaking with a senior patient at the counter while reviewing a prescription bottle and printed plan information

    How do the new 2026 Part D out‑of‑pocket rules limit what you pay?

    Beginning in 2026, the Part D annual out‑of‑pocket threshold is $2,100. After you hit that threshold, you pay $0 for covered Part D prescriptions for the rest of the calendar year. This is an inflation‑adjusted update to the new cap that began in 2025. The coverage gap (“donut hole”) is eliminated under the redesign.

    The redesign also preserved two IRA savings already in place: $35 monthly caps on each covered insulin and $0 cost‑sharing for ACIP‑recommended adult vaccines under Part D. These protections remain for 2026 and can be a major help for Florida retirees with diabetes and for those keeping up with shingles or RSV shots. These standardized limits apply regardless of which Florida plan you choose.

    Do Medicare 2026 drug price changes in Florida mean your premiums will fall?

    Premiums are set by each plan and vary by Florida county, pharmacy network, and benefit design, so there’s no single statewide answer. CMS signaled that 2026 marks a transition back toward more typical market conditions after a 2025 premium stabilization effort, so some plans may adjust premiums or formularies as they incorporate negotiated drug prices and new liability rules. The bottom line: compare options—not just premiums—using your own medication list. Total annual drug cost is the metric that matters.

    What does “plans must cover the negotiated drugs” actually mean for you?

    Under the law, Medicare prescription drug plans—including stand‑alone Part D and Medicare Advantage‑Prescription Drug plans—must include the selected drugs with negotiated prices on their formularies starting January 1, 2026. However, plans can still place drugs on different tiers or apply prior authorization or step‑therapy rules, all of which affect what you pay. Always check tier, restrictions, and preferred pharmacies for your Florida ZIP code.

    How should Florida beneficiaries compare formularies before Annual Enrollment?

    For 2026, the smartest Florida strategy is to run a fresh, drug‑specific comparison. Even small tier or network shifts can outweigh a lower monthly premium.

    • Build a current list of each medication, dose, and frequency.
    • Use Medicare’s Plan Finder to enter your Florida ZIP code and preferred pharmacies, then load your saved drug list (or enter it manually) to sort by lowest total cost.
    • Open each plan’s drug list (formulary) details to confirm tier level, prior authorization, or quantity limits for every med.
    • Check both retail and mail‑order pricing; some plans favor specific Florida chains or local independents via preferred cost‑sharing.
    • See if the plan participates in the Medicare Prescription Payment Plan so you can spread costs in monthly installments if you expect to hit the cap early.

    What Floridians taking Eliquis, Xarelto, Jardiance, or Stelara should do this fall

    If you take one of the newly negotiated drugs, 2026 pricing may change which plan is the best fit for you in Clay, Duval, or St. Johns counties. Because plans must include these medications, your key variables are the tier, coinsurance vs. copay, and your preferred pharmacy’s status.

    • Eliquis/Xarelto users: Compare coinsurance levels and pharmacy networks; even with negotiated prices, cost‑sharing can differ by plan.
    • Jardiance/Farxiga/Januvia users: Verify whether your plan keeps these on a preferred tier and whether step therapy applies.
    • Stelara/Enbrel/Imbruvica users: High‑cost specialty drugs hit the cap faster; confirm specialty pharmacy rules and consider the Payment Plan to smooth cash flow.
    • Insulin aspart (Fiasp/NovoLog) users: You’ll continue to benefit from the $35 insulin cap, with negotiated pricing adding further predictability.

    How the $2,100 cap actually works at the pharmacy in 2026

    You’ll first pay your plan’s deductible (if any), then cost‑sharing during initial coverage. Once your tracked true out‑of‑pocket (TrOOP) costs hit $2,100 in 2026, your copays and coinsurance drop to $0 for covered Part D drugs for the rest of the year. That protection resets each January 1.

    If large fills early in the year would strain your budget, ask whether your plan supports the Medicare Prescription Payment Plan. This program lets you spread your out‑of‑pocket costs into capped monthly payments across the year; it doesn’t reduce costs, but it can prevent early‑year sticker shock for high‑cost therapies. It’s available on all Part D plans.

    Key 2025–2026 dates Florida Medicare enrollees should mark now

    October 15–December 7, 2025: Medicare Open Enrollment (also called Annual Enrollment). This is when you can switch Part D or Medicare Advantage plans for 2026 coverage, with changes effective January 1, 2026. Review your Annual Notice of Change, update your drug list, and compare plans for your Florida county each fall. Dates are the same every year.

    a couple in Orange Park, Florida sitting at a kitchen table with a laptop open to Medicare.gov, reviewing a printed list of medications with a pen and notepad
    a couple in Orange Park, Florida sitting at a kitchen table with a laptop open to Medicare.gov, reviewing a printed list of medications with a pen and notepad

    Why local guidance matters for Medicare 2026 drug price changes Florida residents face

    Negotiated drug prices plus a redesigned Part D benefit mean 2026 will not look like 2024 or 2025. Florida’s plan lineups, pharmacy networks, and tier structures vary by county—so the “best” plan is the one that matches your exact medication list and preferred pharmacies, not a generic pick. An experienced, Florida‑licensed broker can decode these moving parts and keep you compliant with enrollment timelines. Accuracy now helps you avoid costly mid‑year surprises.

    How Green Insurance Agency helps Florida Medicare members make the right 2026 choice

    Green Insurance Agency is a locally based, independent health and Medicare agency in Orange Park, Florida. Our licensed advisors take an education‑first approach to help you compare Medicare Advantage, stand‑alone Part D, and Medigap options—along with dental, vision, life, and final expense when needed—so your coverage supports both your health and budget.

    Here’s how we can assist with the 2026 transition:

    • Drug‑by‑drug plan modeling using Medicare’s Plan Finder for your Florida ZIP code to identify the lowest total annual cost options.
    • Formulary and utilization check for tier placement, prior authorization, and step therapy on your actual prescriptions.
    • Pharmacy network analysis to compare preferred vs. standard cost sharing at your nearby pharmacies.
    • Out‑of‑pocket cap planning so you understand how and when you’ll reach $2,100 in 2026 and whether the Payment Plan makes sense.
    • Enrollment support during the October 15–December 7 window so your 2026 coverage starts smoothly on January 1.

    Ready to see which 2026 plan actually fits your prescriptions? Schedule a no‑cost consultation with Green Insurance Agency—we’ll review your medications, preferred doctors and pharmacies, and budget to recommend the most suitable options for your Florida county. Visit greenins.com to get started today.

    Sources and further reading

    • Centers for Medicare & Medicaid Services (CMS), “Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026” (Fact Sheet and table of 10 drugs; effective Jan 1, 2026).
    • CMS, “Final CY 2026 Part D Redesign Program Instructions” (Out‑of‑pocket threshold $2,100; elimination of coverage gap; $35 insulin and $0 vaccines).
    • Medicare.gov, “Open Enrollment” (Annual Enrollment dates: Oct 15–Dec 7).
    • Medicare.gov, “Explore your Medicare coverage options” (Plan Finder tool for comparing plans using your saved drugs and pharmacies).
    • CMS, “Medicare Prescription Payment Plan” (Monthly payment option for Part D out‑of‑pocket costs).
    • Medicare.gov, “Will this payment option help me?” (Confirms $2,100 Part D out‑of‑pocket maximum for 2026).

    This article is for informational purposes only and does not constitute financial advice. Consult a qualified professional for your specific situation.

    Sources

    Have Medicare Questions? We Have Answers.